The Journal of Immunology, Vol 150, Issue 3 909-915, Copyright © 1993 by American Association of Immunologists

ARTICLES

The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recovery

RR Montgomery, MH Nathanson and SE Malawista
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510.

The macrophage is a known reservoir for a number of infectious agents, and is therefore a likely candidate site for persistence of Borrelia burgdorferi, the Lyme spirochete. We report that unopsonized B. burgdorferi enter macrophages rapidly, resulting mainly in degradation but occasionally in apparent intracellular persistence. We studied uptake of spirochetes by macrophages by simultaneously labeling infected cells with antibodies to B. burgdorferi and with sequential components of the endocytic pathway, and we examined optical sections (0.5-1.0 micron in thickness) of these cells by confocal fluorescence microscopy at multiple time points after infection. We found that only 5 min of incubation at 37 degrees C were required for nearly 100% of B. burgdorferi to enter a lysosomal glycoprotein-positive compartment, whereas 60 min were required for 90% of the spirochetes to appear in a cathepsin L-positive compartment under the same conditions. We also labeled infected living cells with acridine orange to distinguish live from killed intracellular organisms. Although the large majority of spirochetes within a given cell were dead, we saw occasional live ones up to 24 h (the longest interval examined) after all extracellular organisms had been lysed in distilled water. Moreover, we can reculture spirochetes from macrophages after infection. Persistence of spirochetes within macrophages provides a possible pathogenetic mechanism for chronic or recurrent Lyme disease in man.

This article has been cited by other articles:

				O. S. Shin, R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera, and L. T. Hu Distinct Roles for MyD88 and Toll-Like Receptors 2, 5, and 9 in Phagocytosis of Borrelia burgdorferi and Cytokine Induction Infect. Immun., June 1, 2008; 76(6): 2341 - 2351. [Abstract] [Full Text] [PDF]

				J. A. Livengood, V. L. Schmit, and R. D. Gilmore Jr. Global Transcriptome Analysis of Borrelia burgdorferi during Association with Human Neuroglial Cells Infect. Immun., January 1, 2008; 76(1): 298 - 307. [Abstract] [Full Text] [PDF]

				R. R. Montgomery, C. J. Booth, X. Wang, V. A. Blaho, S. E. Malawista, and C. R. Brown Recruitment of Macrophages and Polymorphonuclear Leukocytes in Lyme Carditis Infect. Immun., February 1, 2007; 75(2): 613 - 620. [Abstract] [Full Text] [PDF]

				D. D. Bolz, R. S. Sundsbak, Y. Ma, S. Akira, J. H. Weis, T. G. Schwan, and J. J. Weis Dual Role of MyD88 in Rapid Clearance of Relapsing Fever Borrelia spp. Infect. Immun., December 1, 2006; 74(12): 6750 - 6760. [Abstract] [Full Text] [PDF]

				R. R. Montgomery, K. Schreck, X. Wang, and S. E. Malawista Human Neutrophil Calprotectin Reduces the Susceptibility of Borrelia burgdorferi to Penicillin Infect. Immun., April 1, 2006; 74(4): 2468 - 2472. [Abstract] [Full Text] [PDF]

				S. Al-Robaiy, J. Knauer, and R. K. Straubinger Borrelia burgdorferi Organisms Lacking Plasmids 25 and 28-1 Are Internalized by Human Blood Phagocytes at a Rate Identical to That of the Wild-Type Strain Infect. Immun., September 1, 2005; 73(9): 5547 - 5553. [Abstract] [Full Text] [PDF]

				N. Liu, R. R. Montgomery, S. W. Barthold, and L. K. Bockenstedt Myeloid Differentiation Antigen 88 Deficiency Impairs Pathogen Clearance but Does Not Alter Inflammation in Borrelia burgdorferi-Infected Mice Infect. Immun., June 1, 2004; 72(6): 3195 - 3203. [Abstract] [Full Text] [PDF]

				R. R. Montgomery, D. Lusitani, A. de Boisfleury Chevance, and S. E. Malawista Tick Saliva Reduces Adherence and Area of Human Neutrophils Infect. Immun., May 1, 2004; 72(5): 2989 - 2994. [Abstract] [Full Text] [PDF]

				P. Kraiczy, J. Hellwage, C. Skerka, H. Becker, M. Kirschfink, M. M. Simon, V. Brade, P. F. Zipfel, and R. Wallich Complement Resistance of Borrelia burgdorferi Correlates with the Expression of BbCRASP-1, a Novel Linear Plasmid-encoded Surface Protein That Interacts with Human Factor H and FHL-1 and Is Unrelated to Erp Proteins J. Biol. Chem., January 23, 2004; 279(4): 2421 - 2429. [Abstract] [Full Text] [PDF]

				M. Pausa, V. Pellis, M. Cinco, P. G. Giulianini, G. Presani, S. Perticarari, R. Murgia, and F. Tedesco Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule J. Immunol., March 15, 2003; 170(6): 3214 - 3222. [Abstract] [Full Text] [PDF]

				D. Cadavid, A. R. Pachner, L. Estanislao, R. Patalapati, and A. G. Barbour Isogenic Serotypes of Borrelia turicatae Show Different Localization in the Brain and Skin of Mice Infect. Immun., May 1, 2001; 69(5): 3389 - 3397. [Abstract] [Full Text] [PDF]

				S. Linder, C. Heimerl, V. Fingerle, M. Aepfelbacher, and B. Wilske Coiling Phagocytosis of Borrelia burgdorferi by Primary Human Macrophages Is Controlled by CDC42Hs and Rac1 and Involves Recruitment of Wiskott-Aldrich Syndrome Protein and Arp2/3 Complex Infect. Immun., March 1, 2001; 69(3): 1739 - 1746. [Abstract] [Full Text] [PDF]

				M. Kuthejlova, J. Kopecky, G. Stepanova, and A. Macela Tick Salivary Gland Extract Inhibits Killing of Borrelia afzelii Spirochetes by Mouse Macrophages Infect. Immun., January 1, 2001; 69(1): 575 - 578. [Abstract] [Full Text] [PDF]

				S. E. Malawista, R. R. Montgomery, X.-M. Wang, L. L. Fu, and S. S. Giles Geographic clustering of an outer surface protein A mutant of Borrelia burgdorferi. Possible implications of multiple variants for Lyme disease persistence Rheumatology, May 1, 2000; 39(5): 537 - 541. [Abstract] [Full Text] [PDF]